Researchers Find That Hundreds of Cancer Mutations Share a Common Weakness (Which Is Good News for Treatment)

Scientists built a platform called PerturbFate that found hundreds of cancer mutations converge on shared regulatory hubs, so targeting one common weak spot could fight drug resistance without needing a separate treatment for every genetic mistake.